Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump with integrated motors and sensors
Danvers, MA
NASDAQ: ABMD
Contact: Marty Sutter
Formerly Known As: Impella CardioSystems
Related News
Abiomed Cleared to Sell New Heart Pump
Operates medical adult day care centers that are an alternative to nursing home or institutional care
Owings Mills, MD
Contact: Richard Kolodziejcyk
Formerly Known As: Active Services
Develops abuse deterrent abuse resistant formulations in analgesics
Palatine, IL
NASDAQ: ACUR
Contact: Immanuel Thangaraj
Formerly Known As: Halsey Drug Company
Provides software, services, information and connectivity solutions to enable healthcare providers to deliver best-in-class patient safety, clinical outcomes and financial results
NASDAQ: MDRX
Contact: Jim Currie
Formerly Known As: Allscripts
Provides medical devices for the treatment of structural heart diseases
Minneapolis, MN
NASDAQ: ATSI
Contact: Marty Sutter
Acquisition
Acquired by: Medtronic
Exit date: April 29, 2010
![]()
Enables employers to control costs with a benefits strategy that provides employees with a choice of competing health plans, provider networks, benefit products, plan designs and price points
San Mateo, CA
Contact: Steve Wiggins
Formerly Known As: Emerge Healthcare
Produces injectable implant products used in minimally invasive soft tissue augmentation procedures
San Mateo, CA
NASDAQ: BFRM
Contact: Marty Sutter
Acquisition
Acquired by: Merz Pharma Group
Exit date: January 04, 2010

Related News
Merz to Acquire BioForm Medical
Rapidly growing Latin American specialty pharma company
Bogota, Colombia
Contact: Toby Sykes
Related News
Lured by Rising Healthcare Demand, Essex Woodlands Enters Latin America
Leading orthopedic biologics company
Durham, NC
Contact: Marty Sutter
Related News
Essex Woodlands Announces Launch of Bioventus, a Strategic Partnership with Smith & Nephew
Develops and manages freestanding outpatient clinics focused on the diagnosis, treatment, and management of chronic airway diseases.
Nashville, TN
Contact: Tamara Elias
Related News
BreatheAmerica Secures Series B Financing Totaling $22M
Delivers targeted care management which navigates advanced chronic conditions by providing at-home telemonitoring and home visits to support the most vulnerable patients.
Coral Springs, FL
Contact: Richard Kolodziejcyk
Engineers and develops therapeutic protease products
South San Francisco, CA
Contact: Jeff Himawan
Related News
Collects, processes and cryogenically freezes storage of stem cells
San Bruno, CA
Contact: Immanuel Thangaraj
Emerging biopharmaceutical company which develops novel products to address unmet medical needs
Malvern, PA
NASDAQ: CEPH
Contact: Jeff Himawan
Acquisition
Acquired by: Cephalon, Inc.
Exit date: April 06, 2010
Related News
Cephalon Completes Acquisition of Ception Therapeutics
Leads in the Chinese cord blood collection industry
Beijing, China
NASDAQ: CO
Contact: Immanuel Thangaraj
Exit date: November 30, 2009
Related News
One Size Doesn’t Fit All: Round Table on China - Ernst & Young 2010 Medical Technology Report
Identifies novel anti-cancer agents that combine the efficacy of cytotoxics with the tumor cell selectivity of modern targeted therapeutics.
Abingdon, United Kingdom
Contact: Petri Vainio
Related News
Develops complete human genome sequencing and analysis
Mountain View, CA
NASDAQ: GNOM
Contact: Tom Caskey
IPO
Exit date: November 11, 2010
Related News
Scientists Report New Method of Whole-Genome Sequencing
Develops products to address the need for surgical sealing and post-surgical adhesion prevention applications
Waltham, MA
NYSE: TYC
Contact: Marty Sutter
Acquisition
Acquired by: Tyco International
Exit date: July 18, 2006
![]()
Related News
Who Are the Most Innovative CEOs in Medtech?
Develops drug delivery products and devices using proprietary Corplex hydrogel technology
Menlo Park, CA
Contact: Ron Eastman
Formerly Known As: Stratagent Life Sciences
Related News
Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors
Develops innovative therapeutics targeting cancer network disruption
Cambridge, MA
NASDAQ: CRIS
Contact: Marty Sutter
Formerly Known As: Reprogenesis
Develops topical formulations for pharmaceutical and biotech companies
Petaluma, CA
NYSE: VRX
Contact: Jim Currie
Acquisition
Acquired by: Valeant Pharmaceuticals International
Exit date: December 10, 2008
![]()
Related News
Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Develops the DeBakey ventricular assist device as bridge to heart transplant
Houston, TX
None: MMCO
Contact:

